Correction: Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antivirals Authors: Reem El-Shenawy, Rehab I Moustafa, Naiera M Helmy, Yasmine S El-Abd, Ashraf A Tabll, Yasser K Elesnawy, Heba Shawky Published: 2024 Correction: Virology Journal (2024) 21:293 10.1186/s12985-024-02551-3 In the online published article 10.1186/s12985-024-02551-3, the sentence beginning “No significant difference was detected” in the Results of abstract section was incorrect. The author would like to correct it. The sentence in the Results section should be corrected as: No significant difference was detected in the serum levels of the three markers between cirrhotic and non-cirrhotic patients of chronic HCV, whereas their levels were significantly different between cirrhotic and non-cirrhotic SVRs (P < 0.0001). And, the sentence beginning with “The proposed HCC predictors are” in the Conclusion of the abstract section needs to be replaced with the following text: “Serum sCD163, IL-10, IL-12 and peripheral Cldn1 and TGF-β expression levels represent”. The original article has been corrected. Footnotes The online version of the original article can be found at 10.1186/s12985-024-02551-3. Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Reem El-Shenawy, Rehab I. Moustafa and Naiera M. Helmy are share co-first authorship. References